Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Ampronix
Schiller

Research Demonstrates MRI Acts as Predictive Marker for Epilepsy Development Following Febrile Seizure

By Medimaging International staff writers
Posted on 16 Jul 2014
Within hours of a fever-induced seizure, magnetic resonance imaging (MRI) may be able to identify brain changes that occur in those most likely to develop epilepsy later in life, according to recent animal research. The findings may soon help improve ways to detect children at an increased risk for developing epilepsy and direct efforts to prevent epilepsy development in those at greatest risk.

Convulsions brought on by fever, febrile seizures typically last only a few minutes and are relatively common in infants and small children. However, in some cases, children experience febrile seizures that last for more than 30 minutes (known as febrile status epilepticus [FSE]). Of these children, 40% will go on to develop temporal lobe epilepsy (TLE)—a typical and frequently treatment-resistant brain disorder. Physicians currently have no way to anticipate which of the children with a history of extended febrile seizures (FSE) will go on to develop TLE, and children typically do not experience the beginning of the disease until 10–12 years after the onset of FSE.

Tallie Z. Baram, MD, PhD, and her colleagues at the University of California-Irvine (USA), in this study, used MRI scanning to examine the brains of young rats right after after FSE was induced to compare the brains of the animals that would go on to develop TLE and those that would not. The researchers, who published their findings June 25, 2014, in the Journal of Neuroscience, monitored the rats as they developed over 10 months for signs of TLE. Of the animals that developed epilepsy over the course of the study, all had a distinctive MRI signal in a part of the brain called the amygdala when imaged within hours after the FSE. This signal was not visible in the rats that remained epilepsy-free for the duration of the experiment.

“This remarkable discovery got us to ask two key questions,” Dr. Baram said. “First, can we figure out what is going on in the brain that causes this new signal? And second, can we detect a similar predictive signal in children after febrile status epilepticus?”

Additional study into the origin of the MRI signal revealed that the brains of the lab rats that went on to develop epilepsy were consuming more energy and using up more oxygen in the amygdala hours after long febrile seizures than the brains of the rats that did not develop epilepsy later in life. “Detecting reduced oxygen may be an early marker of brain damage that leads to subsequent spontaneous seizures and epilepsy,” explained Hal Blumenfeld, MD, PhD, who studies epilepsy at Yale University (New Haven, CT, USA), and was not involved in this study.

Although the current study was conducted in rodents using a high-power laboratory scanner, additional studies by Dr. Baram’s group revealed that the epilepsy-predicting signal could be detected using a standard hospital MRI scanner. This indicates that similar evaluations could be done in children with FSE to begin to evaluate whether this signal appears in children after FSE and whether it predicts the emergence of epilepsy later on in life.

“Preventive therapy development is hampered by our inability to identify early the individuals who will develop TLE,” Dr. Baram explained. “Finding a predictive signal using clinically applicable noninvasive brain scans holds promise for predicting epilepsy after FSE.”

Related Links:

University of California-Irvine



Channels

Radiography

view channel
Image: Fujifilm\'s Aspire Cristalle (Photo courtesy of Business Wire).

Diagnostic Imaging Solutions Provider Submits Mammography Upgrade for FDA Approval

A leading provider of medical informatics solutions and diagnostic imaging products has submitted the first of several modules of its Digital Breast Tomosynthesis (DBT) upgrade for its mammography system,... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: The Arbor Solution M2150 medical workstation with 21.5\

Multifunction Workstation Screen Meets Critical Certification Standards for Medical Environments

A medical imaging equipment vendor has unveiled a new workstation with a 54.61 cm true flat screen designed for operating rooms, clinical stations, and Picture Archiving and Communications Systems (PACS).... Read more

Industry News

view channel

Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK). The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.